Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes

Immune checkpoint inhibitor (ICI) immunotherapies have vastly improved therapeutic outcomes for patients with certain cancer types, but these responses only manifest in a small percentage of all cancer patients. The goal of the present study was to improve checkpoint therapy efficacy by utilizing an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biosci Rep
Hlavní autoři: Lou, Jiaying, Dong, Jialin, Xu, Ruijun, Zeng, Hui, Fang, Lijuan, Wu, Yi, Liu, Yang, Wang, Shibing
Médium: Artigo
Jazyk:Inglês
Vydáno: Portland Press Ltd. 2021
Témata:
Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193643/
https://ncbi.nlm.nih.gov/pubmed/34060602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20204186
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky